Alerts will be sent to your verified email
Verify EmailTITANBIO
Titan Bio-Tech
|
Naperol Investments
|
Ganesh Benzoplast
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
25.7 % | 5.47 % | 14.38 % |
5yr Avg Net Profit Margin
|
16.03 % | 18.23 % | 11.37 % |
Price to Book
|
4.04 | 0.46 | 1.29 |
P/E
|
28.14 | 49.39 | 17.52 |
5yr Avg Cash Conversion Cycle
|
113.51 Days | 13.07 Days | -29.1 Days |
5yr Average Interest Coverage Ratio
|
26.4 | 126.22 | 12.87 |
5yr Avg ROCE
|
31.72 % | 7.9 % | 19.47 % |
5yr Avg Operating Profit Margin
|
23.23 % | 29.16 % | 22.59 % |
5 yr average Debt to Equity
|
0.2 | 0.1 | 0.17 |
5yr CAGR Net Profit
|
28.58 % | -43.68 % | 12.79 % |
5yr Average Return on Assets
|
17.56 % | 4.72 % | 9.17 % |
Shareholdings
|
|||
Promoter Holding
|
55.88 % | 70.76 % | 39.02 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -5.49 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Titan Bio-Tech
|
Naperol Investments
|
Ganesh Benzoplast
|
---|